Inventor · disambiguated record
Mark Krebs
Also filed as: KREBS MARK · KREBS MARK P · KREBS MARK R H
0 granted patents·5 pending applications·0 citations·filing 2003–2025
Top patents by PatentIndex Score
5 records- 0156US2025289895A1Pharmaceutical compositions and dosage regimens for clinical use of anti-blood dendritic cell antigen 2 antibodiesBIOGEN MA INC·Filed 2025·Application pending·0 cites
- 0248US2004248202A1Bacteriorhodopsin/G protein-coupled receptor chimerasWISCONSIN ALUMNI RES FOUND·Filed 2003·Application pending·0 cites
- 0340US2019284281A1Pharmaceutical compositions and dosage regimens for clinical use of anti-blood dendritic cell antigen 2 antibodiesBIOGEN MA INC·Filed 2017·Application pending·0 cites
- 0434US2018264112A1Anti-CD40 Antibody FormulationsBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 0532US2019064147A1Formulations and screening of biological therapeutic agentsBIOGEN MA INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Krebs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →